9fyj: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "9fyj" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
==N-terminal domain of human galectin-8 in complex with an alpha-galactoside ligand== | |||
<StructureSection load='9fyj' size='340' side='right'caption='[[9fyj]], [[Resolution|resolution]] 1.08Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[9fyj]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9FYJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9FYJ FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.08Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A1IHE:2-[[(2~{R},3~{R},4~{S},5~{S},6~{R})-2-(3,4-dichlorophenyl)sulfanyl-6-(hydroxymethyl)-5-oxidanyl-3-prop-2-ynoxy-oxan-4-yl]oxymethyl]-3-methyl-benzimidazole-5-carboxylic+acid'>A1IHE</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9fyj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9fyj OCA], [https://pdbe.org/9fyj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9fyj RCSB], [https://www.ebi.ac.uk/pdbsum/9fyj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9fyj ProSAT]</span></td></tr> | |||
</table> | |||
== Function == | |||
[https://www.uniprot.org/uniprot/LEG8_HUMAN LEG8_HUMAN] Lectin with a marked preference for 3'-O-sialylated and 3'-O-sulfated glycans.<ref>PMID:21288902</ref> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Galectin-8 is a tandem-repeat galectin consisting of two distinct carbohydrate recognition domains and is a potential drug target. We have developed a library of galectin-8N inhibitors that exhibit high nanomolar K(d) values as determined by a competitive fluorescence polarization assay. A detailed thermodynamic analysis of the binding of D-galactosides to galectin-8N by isothermal titration calorimetry reveals important differences in enthalpic and/or entropic contributions to binding. Contrary to expectations, the binding of 2-O-propargyl-D-galactoside was found to strongly increase the binding enthalpy, whereas the binding of 2-O-carboxymethylene-D-galactoside was surprisingly less enthalpy-driven. The results of our work suggest that the ethynyl group can successfully replace the carboxylate group when targeting the water-exposed guanidine moiety of a critical arginine residue. This results in only a minor loss of affinity and an adjusted enthalpic contribution to the overall binding due to non-canonical cation-pi interactions, as evidenced by the obtained crystal structure of 2-O-propargyl-D-galactoside in complex with the N-terminal domain of galectin-8. Such an interaction has neither been identified nor discussed to date in a small-molecule ligand-protein complex. | |||
Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-pi interaction.,Puric E, Hassan M, Sjovall F, Tomasic T, Pevec M, Lah J, Forteza JA, Sundin A, Leffler H, Nilsson UJ, Logan DT, Anderluh M Commun Chem. 2025 Feb 24;8(1):59. doi: 10.1038/s42004-025-01458-6. PMID:39994474<ref>PMID:39994474</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
[[Category: | </div> | ||
[[Category: | <div class="pdbe-citations 9fyj" style="background-color:#fffaf0;"></div> | ||
[[Category: | == References == | ||
[[Category: | <references/> | ||
[[Category: | __TOC__ | ||
[[Category: | </StructureSection> | ||
[[Category: Homo sapiens]] | |||
[[Category: Large Structures]] | |||
[[Category: Adrover Forteza J]] | |||
[[Category: Anderluh M]] | |||
[[Category: Logan DT]] | |||
[[Category: Nilsson UJ]] | |||
[[Category: Puric E]] | |||
Latest revision as of 10:33, 12 March 2025
N-terminal domain of human galectin-8 in complex with an alpha-galactoside ligand
| ||||||||||||